Skip to content
naulon

Not checkedNot checked for notices yet.

Use of Recombinant α-2b-Interferon in the Treatment of Acute Respiratory Viral Diseases in Children

O.Ye. Chernyshova

Zdorovʹe Rebenka · 2016

doi:10.22141/2224-0551.6.74.2016.82135 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

The article describes the types and biological features of interferons, which are the part of the child’s body antiviral defense. There are shown the possibilities of using interferons, in particular, α-2b-interferon (Laferobion), in the comprehensive treatment of acute respiratory viral infections in children since the neonatal period.

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.